Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series
Other
- Academic article
Morgan, A; Irons, R; Kwiatt, M; Ho, H; Elfant, A; McClane, S
October 24, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Morgan, A., Irons, R., Kwiatt, M., Ho, H., Elfant, A., & McClane, S. (2018). Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series. Arch Gastroenterol Hepatol. https://doi.org/10.29011/AGEH-104
Morgan, Andrew, Robin Irons, Michael Kwiatt, Henry Ho, Adam Elfant, and Steven McClane. “Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series.” Arch Gastroenterol Hepatol, October 24, 2018. https://doi.org/10.29011/AGEH-104.
Morgan A, Irons R, Kwiatt M, Ho H, Elfant A, McClane S. Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series. Arch Gastroenterol Hepatol; 2018.
Morgan, Andrew, et al. Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series. 24 Oct. 2018. Manual, doi:10.29011/AGEH-104.
Morgan A, Irons R, Kwiatt M, Ho H, Elfant A, McClane S. Use of Stenting for Obstructing Rectal Cancer as a Bridge to Neoadjuvant Therapy and Surgery: A Case Series. Arch Gastroenterol Hepatol; 2018.